Tangible Shareholders Equity (Quarterly)

Tangible Shareholders Equity: The value shareholders equity less intangible assets.

Pfizer Inc. (PFE) had Tangible Shareholders Equity of $-35.44B for the most recently reported fiscal quarter, ending 2024-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2024-12-31

Income Statement Financials
Revenue	$17.76B
Net Income	$410.00M
Cost of Goods Sold	$5.91B
Gross Profit	$11.85B
Operating Expenses	$15.42B
Operating Income	$2.35B
Non-Operating Income/Expense	$-2.36B
Pre-Tax Income	$-10.00M
Normalized Pre-Tax Income	$-10.00M
Income after Taxes	$411.00M
Income from Continuous Operations	$411.00M
Consolidated Net Income/Loss	$418.00M
Normalized Income after Taxes	$411.00M
EBIT	$2.35B
EBITDA	$4.14B
Weighted-Average Shares Outstanding (Basic)	5.66B
Weighted-Average Shares Outstanding (Diluted)	5.70B
Earnings per Share (EPS) (Basic)	$0.07
Earnings per Share (EPS) (Diluted)	$0.07
Balance Sheet Financials
Current Assets	$50.36B
Property, Plant, and Equipment	$18.39B
Long-Term Assets	$163.04B
Total Assets	$213.40B
Current Liabilities	$42.99B
Long-Term Debt	$57.41B
Long-Term Liabilities	$81.90B
Total Liabilities	$124.90B
Common Equity	$88.50B
Tangible Shareholders Equity	$-35.44B
Shareholders Equity	$88.50B
Common Shares Outstanding	5.67B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$12.74B
Cash Flow from Investing Activities	$2.65B
Cash Flow from Financial Activities	$-17.14B
Beginning Cash	$2.92B
End Cash	$1.11B
Increase/Decrease in Cash	$-1.81B
Stock-Based Compensation	$877.00M
Common Stock Dividends Paid	$-9.51B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.17
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.39
Debt to Equity Ratio	0.73
Gross Margin	66.73%
Operating Margin	13.21%
EBIT Margin	13.21%
EBITDA Margin	--
Pre-Tax Profit Margin	-0.06%
Profit Margin	2.31%
Free Cash Flow	$9.84B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.08
Inventory Turnover	0.54
Receiveable Turnover	1.55
Days Sales in Receivables	58.08
Return on Equity	0.46%
Return on Tangible Equity	-1.16%
Return on Assets	0.19%
Return on Investments	0.28%
Book Value Per Share	$15.62
Free Cash Flow per Share	$1.73
Operating Cash Flow per Share	$2.24

Data from Zacks Investment Research, Inc.